Acrx stock forecast.

The 2 analysts offering 1 year price forecasts for ACRX have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to ACRX in the past 3 months.Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ...Currently 8 wall-street analysts regularly analyze the financials of Acelrx Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 8 analysts offering 12-month price forecasts for Acelrx Pharmaceuticals, Inc. (ACRX) have a share price target of $4.63.Dec 1, 2023 · View AcelRx Pharmaceuticals, Inc ACRX investment & stock information. Get the latest AcelRx Pharmaceuticals, Inc ACRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Data as of 3:59pm ET, 11/21/2023 Financials Profile Forecasts Paid Partner Paid Partner Find real-time ACRX - AcelRx Pharmaceuticals Inc stock quotes, company profile, news and forecasts...

AcelRx Pharmaceuticals raised capital in December 2022, causing a roughly 50% dilution of existing shareholders on a fully diluted basis. Find out why ACRX stock is a Hold.

377.43. -0.11%. 9.38M. View today's AcelRx Pharmaceuticals Inc stock price and latest ACRX news and analysis. Create real-time notifications to follow any changes in the live stock price.1.49%. $75.35M. Cara Therapeutics Inc. 13.45%. $73M. ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.65, with a high estimate of 9.50 and a low estimate of 3.80. The ... Data as of 3:59pm ET, 11/21/2023 Financials Profile Forecasts Paid Partner Paid Partner Find real-time ACRX - AcelRx Pharmaceuticals Inc stock quotes, company profile, news and forecasts...

1 Wall Street research analysts have issued 1-year price targets for Acurx Pharmaceuticals' stock. Their ACXP share price targets range from $13.00 to $13.00. On average, they predict the company's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 244.8% from the stock's current price.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Athersys Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate ...

Acelrx Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "ACRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Acelrx Pharmaceuticals Inc (ACRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Find real-time IMGN - ImmunoGen Inc stock quotes, company profile, news and forecasts from CNN Business.What is the current Price Target and Forecast for AcelRx Pharmaceuticals (ACRX) AcelRx Pharmaceuticals (ACRX) (Delayed Data from NSDQ) $0.48 USD 0.00 (-0.25%) Updated Nov 16, 2023 03:59 PM ET...ACRX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Acelrx in the last 3 months. The average price target is $5.00 with a high …

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Inpixon have a median target of 586,488.00, with a high estimate of 586,488.00 and a low estimate of 586,488.00. The ...AcelRx Pharmaceuticals Inc AcelRx Pharmaceuticals Inc ACRX Morningstar Rating Unlock Stock XNAS Rating as of Nov 17, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns...Revolution Medicines, Inc. (RVMD), another stock in the Zacks Medical - Drugs industry, is expected to report earnings per share of $0.84 for the quarter ended March 2023. This estimate points to ...The stock boasts 4 recent buy ratings vs just 1 hold rating. This is with an $7.75 average price target, suggesting shares could surge 113%. Get the ACRX Stock Research Report.Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Verona Pharma PLC have a median target of 32.00, with a high estimate of 38.00 and a low estimate of 31.00. The median ...Acacia Research Corporation (ACTG) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACTG one year forecast. Acacia Research stock monthly and weekly forecasts.What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.

We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...2 Wall Street analysts have issued twelve-month price targets for AcelRx Pharmaceuticals' stock. Their ACRX share price targets range from $4.25 to $5.00. On average, they expect the company's share price to reach $4.63 in the next twelve months. This suggests a possible upside of 670.8% from the stock's current price.

AcelRx Pharmaceuticals (NASDAQ:ACRX) dropped ~15% aftermarket as the firm will effect a 1-for-20 reverse stock split on Tuesday at 5.01 pm ET.The company's stock will begin trading on a split ...Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ...Dec 1, 2023 · Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for ACRX stock stock is $4.63, which predicts an increase of 623.55%. The lowest target is $4.25 and the highest is $5.00. On average, analysts rate ACRX stock stock as a strong buy. AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

AcelRx Pharmaceuticals raised capital in December 2022, causing a roughly 50% dilution of existing shareholders on a fully diluted basis. Find out why ACRX stock is a Hold.

1 January 2022 / pennystocks.com / 4 min read Top Penny Stocks To Buy According To Analysts & Targets Up To 615%222.96%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -4.11M. 12.66%. Get the latest Achieve Life Sciences Inc ...Acurx Pharmaceuticals, Inc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for each of five key investing factors: value, growth, momentum, earnings revisions and quality. Here, we’ll take a closer look at AcelRx Pharmaceuticals Inc’s stock grades for value, growth and quality.1 Wall Street research analysts have issued 1-year price targets for Acurx Pharmaceuticals' stock. Their ACXP share price targets range from $13.00 to $13.00. On average, they predict the company's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 244.8% from the stock's current price.AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Welcome to the AcelRx third quarter 2023 financial results conference call.Nabriva Therapeutics plc (NASDAQ:NBRV) announced its quarterly earnings data on Thursday, May, 6th. The biotechnology company reported ($13.25) EPS for the quarter, beating analysts' consensus estimates of ($16.75) by $3.50. The biotechnology company earned $2.53 million during the quarter, compared to analysts' expectations of …Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

Currently 8 wall-street analysts regularly analyze the financials of Acelrx Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 8 analysts offering 12-month price forecasts for Acelrx Pharmaceuticals, Inc. (ACRX) have a share price target of $4.63.ACRX is currently rated as a Sucker Stock | Stockopedia. Login Get Started. ... Is there a AcelRx Pharmaceuticals share price forecast for 2023? The analyst consensus target price for shares in AcelRx Pharmaceuticals is $4.12. That is …Sign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023. Next Earnings (Estimated) +423.4%. $-26,640,000.00.Instagram:https://instagram. fha home loans ohionasdaq usoifreeport mcmoran copper and gold stockbest currency trading strategy The stock boasts 4 recent buy ratings vs just 1 hold rating. This is with an $7.75 average price target, suggesting shares could surge 113%. Get the ACRX Stock Research Report. rare quarters worth moneyhow to buy puts AcelRx Pharmaceuticals (ACRX) Stock Forecast & Price Prediction. Estimation of the future price movement of AcelRx Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions. 1.14,241.02 -9.83(-0.07%) Russell 2000 1,801.15 -6.35(-0.35%) Crude Oil 75.02 -0.52(-0.69%) Gold 2,014.40 +11.40(+0.57%) Advertisement AcelRx Pharmaceuticals, Inc. (ACRX) NasdaqGM - NasdaqGM Real... best family dental plan Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Currently 8 wall-street analysts regularly analyze the financials of Acelrx Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 8 analysts offering 12-month price forecasts for Acelrx Pharmaceuticals, Inc. (ACRX) have a share price target of $4.63.